Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds
- 30 November 1991
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer and Clinical Oncology
- Vol. 27 (11), 1361-1366
- https://doi.org/10.1016/0277-5379(91)90010-b
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft modelBritish Journal of Cancer, 1990
- The potential of carboxypeptidase G2: antibody conjugates as anti-tumour agents. II. In vivo localising and clearance properties in a choriocarcinoma modelBritish Journal of Cancer, 1990
- Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2Journal of Medicinal Chemistry, 1990
- A cytotoxic agent can be generated selectively at cancer sitesBritish Journal of Cancer, 1988
- Antibody directed enzymes revive anti-cancer prodrugs conceptBritish Journal of Cancer, 1987
- Mapping epitope characteristics on carcinoembryonic antigenBritish Journal of Cancer, 1986
- Distribution of intact and Fab1 2 fragments of anti-human chorionic gonadotrophin antibodies in nude mice bearing human choriocarcinoma xenograftsCancer Immunology, Immunotherapy, 1986
- The potential of carboxypeptidase G2-antibody conjugates as anti-tumour agents. I. Preparation of antihuman chorionic gonadotrophin-carboxypeptidase G2 and cytotoxicity of the conjugate against JAR choriocarcinoma cells in vitroBritish Journal of Cancer, 1986
- Preparation and properties of a mouse monoclonal antibody (W14A) to human chorionic gonadotropinInternational Journal of Cancer, 1984
- A new reagent which may be used to introduce sulfhydryl groups into proteins, and its use in the preparation of conjugates for immunoassayAnalytical Biochemistry, 1983